Overview
- 3 inspections across 3 sites are on record.
- 4 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-07-19.
At a glance
Inspections
3
Sites
3
Observations
4
Career since
Mar 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Polypeptide Laboratories Inc | 19 Jul 2017 | Human Drugs | On file |
| Nitto Avecia Pharma Services, Inc. | 21 Apr 2017 | Human Drugs | On file |
| Element Materials Technology Pharma US LLC | 25 Mar 2016 | Animal Drugs & Feeds | View 483 → |
Sites inspected
Polypeptide Laboratories IncTorrance, United States1 insp.
Nitto Avecia Pharma Services, Inc.Irvine, United States1 insp.
Element Materials Technology Pharma US LLCSanta Fe Springs, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Kathy Chiu2 shared
Bichsa T Tran1 shared
Santiago Gallardo Johnson1 shared
Kenneth H Williams1 shared
Alan P Kurtzberg1 shared
Nicholas L Hunt1 shared
Darren S Brown1 shared
Amanda L Fyles1 shared
Full investigator report
Get the verbatim findings behind Kathy Kuo's 4 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site